{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:05:33Z","timestamp":1726495533314},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.leukres.2008.06.026","type":"journal-article","created":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T05:18:27Z","timestamp":1217567907000},"page":"237-243","source":"Crossref","is-referenced-by-count":24,"title":["CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Wei","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Xia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2008.06.026_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2008.06.026_bib3","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib4","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood.V97.6.1902","article-title":"CD38 expression and Ig VH gene mutation in B-cell chronic lymphocytic leukemia","volume":"97","author":"Matrai","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib6","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood.V98.9.2633","article-title":"Clinical significance of CD38 expression in chronic lymphocytic leukemia","volume":"98","author":"Del Poeta","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.0007-1048.2001.3205.x","article-title":"CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia","volume":"116","author":"Chevallier","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukemia","volume":"16","author":"Durig","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.026_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","article-title":"Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia","volume":"115","author":"Jelinek","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0145-2126(01)00049-2","article-title":"Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia","volume":"25","author":"Morabito","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2008.06.026_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10428190109097682","article-title":"CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia","volume":"42","author":"D\u2019Arena","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2008.06.026_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1080\/10428190127505","article-title":"Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia","volume":"42","author":"Heintel","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2008.06.026_bib13","first-page":"1021","article-title":"CD38 expression in B-cell chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients","volume":"87","author":"Domingo-Domenech","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.06.026_bib14","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2002-06-1801","article-title":"The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression","volume":"101","author":"Ghia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.thj.6200360","article-title":"CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia","volume":"5","author":"Thornton","year":"2004","journal-title":"Hematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.2005.05659.x","article-title":"The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience","volume":"130","author":"Gentile","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cyto.b.20106","article-title":"CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression","volume":"70","author":"Boonstra","year":"2006","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.leukres.2008.06.026_bib18","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1038\/sj.leu.2403147","article-title":"ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia","volume":"17","author":"Durig","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.026_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.leu.2403707","article-title":"Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukaemia","volume":"19","author":"Schroers","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.026_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1532\/IJH97.A10602","article-title":"Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia","volume":"85","author":"Xu","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib22","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2008.06.026_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.leu.2402780","article-title":"Predictive value of serum thymidine kinase level for Ig-V mutational status in B-CLL","volume":"17","author":"Magnac","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2008.06.026_bib24","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib25","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood-2001-11-0066","article-title":"Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia","volume":"100","author":"Lin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib26","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Krober","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2008.06.026_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3324\/haematol.11622","article-title":"Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method","volume":"93","author":"Gachard","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2008.06.026_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2141.2002.03673.x","article-title":"Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia","volume":"118","author":"Mainou-Fowler","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2008.06.026_bib30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1046\/j.1365-2141.2003.04213.x","article-title":"Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia","volume":"120","author":"Hsi","year":"2003","journal-title":"Br J Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608003032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212608003032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:31:59Z","timestamp":1588836719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212608003032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0145212608003032"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2008.06.026","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}